TipRanks
Go Ultimate55% OFF

Compare Eli Lilly & Co (LLY) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MX:LLYEli Lilly & CoMXN 26,620.00MXN 25.05T45.8970.46%Strong BuyMX:LLY
AMGNAmgen$466.01$251.94B28.7359.59%Moderate BuyMX:LLY vs AMGN
MRKMerck & Company$149.52$368.89B152.5773.30%Moderate BuyMX:LLY vs MRK
NVONovo Nordisk$40.00$176.13B10.15-20.06%NeutralMX:LLY vs NVO
PFEPfizer$30.52$173.95B40.3325.65%Moderate BuyMX:LLY vs PFE
ABBVAbbVie$294.89$521.11B83.0829.22%Strong BuyMX:LLY vs ABBV

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MX:LLYEli Lilly & Co26620.0010055.2960.70%
AMGNAmgen466.01177.7161.64%
MRKMerck & Company149.5269.3886.58%
NVONovo Nordisk40.00-7.49-15.78%
PFEPfizer30.527.4832.45%
ABBVAbbVie294.8989.0943.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts